ATE419851T1 - Verwendung von riluzol zur behandlung multipler sklerose - Google Patents
Verwendung von riluzol zur behandlung multipler skleroseInfo
- Publication number
- ATE419851T1 ATE419851T1 AT05001476T AT05001476T ATE419851T1 AT E419851 T1 ATE419851 T1 AT E419851T1 AT 05001476 T AT05001476 T AT 05001476T AT 05001476 T AT05001476 T AT 05001476T AT E419851 T1 ATE419851 T1 AT E419851T1
- Authority
- AT
- Austria
- Prior art keywords
- riluzole
- multiple sclerosis
- treat multiple
- treat
- benzothiazolamine
- Prior art date
Links
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 3
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- 229960004181 riluzole Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99201788 | 1999-06-04 | ||
| US17432800P | 2000-01-04 | 2000-01-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE419851T1 true ATE419851T1 (de) | 2009-01-15 |
Family
ID=56290027
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05001476T ATE419851T1 (de) | 1999-06-04 | 2000-06-02 | Verwendung von riluzol zur behandlung multipler sklerose |
| AT00939007T ATE287713T1 (de) | 1999-06-04 | 2000-06-02 | Verwendung von riluzol zur behandlung multipler sklerose |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00939007T ATE287713T1 (de) | 1999-06-04 | 2000-06-02 | Verwendung von riluzol zur behandlung multipler sklerose |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1552831B1 (enExample) |
| JP (1) | JP2003522121A (enExample) |
| AT (2) | ATE419851T1 (enExample) |
| AU (1) | AU777537B2 (enExample) |
| CA (1) | CA2375874A1 (enExample) |
| DE (1) | DE60017733T2 (enExample) |
| ES (1) | ES2235896T3 (enExample) |
| NZ (1) | NZ515685A (enExample) |
| PT (1) | PT1187612E (enExample) |
| SI (1) | SI1187612T1 (enExample) |
| WO (1) | WO2000074676A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1100504A2 (en) | 1998-07-02 | 2001-05-23 | Eisai Co., Ltd. | Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
| IL136687A0 (en) * | 2000-06-12 | 2001-06-14 | Mor Research Applic Ltd | Pharmaceutical composition for the treatment of multiple sclerosis |
| EP1778286A4 (en) * | 2004-03-03 | 2009-04-08 | Teva Pharma | COMBINATION THERAPY WITH ACETATE OF GLATIRAMER AND RILUZOLE |
| ITMI20061274A1 (it) * | 2006-06-30 | 2008-01-01 | Consiglio Nazionale Ricerche | Vettori nanoparticellari lipidici contenenti riluzolo e composizioni farmaceutiche che li contengono |
| EP2228054A1 (en) | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Riluzole aqueous suspensions |
| WO2010113225A1 (en) * | 2009-03-30 | 2010-10-07 | Yutoku Pharmaceutical Industries Co., Ltd. | Riluzole-containing transdermal patch |
| CA2967659A1 (en) * | 2014-11-21 | 2016-05-26 | Biohaven Pharmaceutical Holding Company Ltd. | Sublingual administration of riluzole |
| US10258611B2 (en) * | 2014-11-26 | 2019-04-16 | Medicinova, Inc. | Combination of ibudilast and riluzole and methods of using same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2688138B1 (fr) * | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
| JPH11513698A (ja) * | 1995-10-25 | 1999-11-24 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 神経保護物質およびパーフルオロケミカルの注射剤 |
| JP3117725B2 (ja) * | 1995-11-15 | 2000-12-18 | 山之内製薬株式会社 | カイニン酸神経細胞毒性阻害剤及びピリドチアジン誘導体 |
| US5728728A (en) * | 1996-04-10 | 1998-03-17 | Kozachuk; Walter E. | Methods of providing neuroprotection |
| IL119989A0 (en) * | 1997-01-10 | 1997-04-15 | Yeda Res & Dev | Pharmaceutical compositions for oral treatment of multiple sclerosis |
| JP4120713B2 (ja) * | 1997-09-04 | 2008-07-16 | 大塚製薬株式会社 | 多発性硬化症治療剤 |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
-
2000
- 2000-06-02 CA CA002375874A patent/CA2375874A1/en not_active Abandoned
- 2000-06-02 PT PT00939007T patent/PT1187612E/pt unknown
- 2000-06-02 WO PCT/IB2000/000933 patent/WO2000074676A1/en not_active Ceased
- 2000-06-02 AT AT05001476T patent/ATE419851T1/de not_active IP Right Cessation
- 2000-06-02 JP JP2001501213A patent/JP2003522121A/ja active Pending
- 2000-06-02 DE DE60017733T patent/DE60017733T2/de not_active Expired - Lifetime
- 2000-06-02 NZ NZ515685A patent/NZ515685A/xx not_active IP Right Cessation
- 2000-06-02 AU AU54219/00A patent/AU777537B2/en not_active Ceased
- 2000-06-02 SI SI200030601T patent/SI1187612T1/xx unknown
- 2000-06-02 EP EP05001476A patent/EP1552831B1/en not_active Expired - Lifetime
- 2000-06-02 AT AT00939007T patent/ATE287713T1/de active
- 2000-06-02 ES ES00939007T patent/ES2235896T3/es not_active Expired - Lifetime
- 2000-06-02 EP EP00939007A patent/EP1187612B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1552831B1 (en) | 2009-01-07 |
| PT1187612E (pt) | 2005-05-31 |
| ES2235896T3 (es) | 2005-07-16 |
| WO2000074676A1 (en) | 2000-12-14 |
| AU777537B2 (en) | 2004-10-21 |
| NZ515685A (en) | 2002-12-20 |
| DE60017733T2 (de) | 2006-01-12 |
| DE60017733D1 (de) | 2005-03-03 |
| SI1187612T1 (en) | 2005-06-30 |
| EP1552831A1 (en) | 2005-07-13 |
| ATE287713T1 (de) | 2005-02-15 |
| JP2003522121A (ja) | 2003-07-22 |
| EP1187612A1 (en) | 2002-03-20 |
| EP1187612B1 (en) | 2005-01-26 |
| AU5421900A (en) | 2000-12-28 |
| CA2375874A1 (en) | 2000-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE313326T1 (de) | VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß | |
| ATE201138T1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose | |
| DE60237635D1 (de) | Verwendung von pramipexol zur behandlung von amyotrophischer lateralsklerose | |
| DE69910368D1 (de) | Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen | |
| ATE304350T1 (de) | Probucol monoester zur behandlung von kreislauf- und entzündungserkrankungen | |
| DE69936335D1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| DE69941566D1 (de) | N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie | |
| ATE179610T1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
| ZA200309808B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| DE60335997D1 (de) | Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus | |
| ATE214274T1 (de) | Antikonvulsiva zur verwendung bei der behandlung von amyotropischer lateralsklerose | |
| DE69532804D1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
| DE60034871D1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| DE69840752D1 (de) | Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen | |
| DE69937624D1 (de) | Verfahren zur Behandlung von Metalloberflächen | |
| ATE287713T1 (de) | Verwendung von riluzol zur behandlung multipler sklerose | |
| DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
| ATE353667T1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| DE60041365D1 (de) | Verwendung von Riluzol zur Behandlung Multipler Sklerose | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE59705697D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |